![]() |
市场调查报告书
商品编码
1476322
到 2030 年超音波气泡检测器市场预测:按产品类型、输出讯号、技术、应用、最终用户和地区进行的全球分析Ultrasonic Air Bubble Detectors Market Forecasts to 2030 - Global Analysis By Product (Portable, Fixed, Batch, Inline, Stand-alone and Other Products), Channel Type, Output Signal, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球超音波气泡检测器市场规模为 1.1517 亿美元,预计在预测期内将以 10.2% 的复合年增长率增长,到 2030 年达到 2.3261 亿美元。
超音波气泡检测器是医疗设备,旨在检测和监测医疗过程中流体管线中是否有气泡。这些检测器利用超音波技术即时识别和量化气泡,有助于防止潜在危险的气泡栓塞进入血液。
根据世界卫生组织(WHO)统计,有近1,790万人使用血氧装置,占全球整体的32%。
慢性病增加
由于糖尿病和肾衰竭等慢性疾病的增加,对配备超音波气泡检测器的输液帮浦和透析设备等医疗设备的需求不断增加。这些检测器在预防空气栓塞相关併发症和确保医疗过程中病患安全方面发挥重要作用。随着全球慢性病盛行率持续上升,对超音波气泡检测器等先进医疗技术的需求不断增长,以支持这些疾病的管理和治疗,从而推动市场成长。
整合复杂度
超音波气泡计的整合复杂性涉及将这些设备无缝整合到现有医疗设备或将其设计到新系统中的挑战。这种复杂性可能会导致产品开发延迟、成本增加以及难以实现监管合规性。因此,医疗保健提供者可能会犹豫是否采用这些检测器,由于担心整合挑战和相关风险而阻碍了市场成长。
越来越注重最大限度地降低医疗成本
人们日益关注最大限度地降低医疗保健成本,透过强调预防措施的重要性来避免代价高昂的併发症,从而推动了超音波气泡检测器的发展。这些检测器有助于预防空气栓塞,并透过减少额外治疗和住院治疗的需要来最大限度地减少医疗支出。透过投资提高病人安全性并降低不利事件发生可能性的技术,医疗保健提供者可以实现长期成本节约,而超音波气泡检测器是一种具有成本效益的健康护理服务中的宝贵资产。
初始投资高
超音波气泡感测器的初始投资较高,是因为需要先进的感测器技术、精密製造和严格的测试,以确保医疗环境中的可靠性和准确性。这些成本可能具有威慑力,特别是对于规模较小的医疗机构或预算有限的机构。大量的前期投资可能被认为是令人望而却步的,因为医疗保健提供者会权衡财务负担和收益,从而阻碍市场成长。
COVID-19 的影响
COVID-19 的爆发对超音波气泡检测器市场产生了各种影响。虽然对输液帮浦和透析设备等医疗设备的需求不断增长正在推动市场,但供应链和医疗服务的中断正在阻碍成长。此外,为应对大流行而改变的医疗保健优先事项和预算限制可能会影响购买决策并减缓市场扩张。整体而言,疫情对全球超音波气泡检测器市场造成了复杂多样的影响。
预计多普勒超音波细分市场在预测期内将是最大的
多普勒超音波领域预计将出现良好的成长。多普勒超音波气泡检测器是医疗设备,用于在透析和心血管手术等过程中监测血液等液体的流动。透过超音波照射液体,根据气泡运动引起的频率变化来检测气泡的存在。它可以进行即时监控,提醒医疗保健专业人员潜在的风险,并能够即时进行干预,以确保患者在关键手术期间的安全。
静脉输液领域预计在预测期内复合年增长率最高。
静脉输液领域预计在预测期内复合年增长率最高。超音波气泡检测器的工作原理是向流体流发射超音波。如果有气泡,超音波就会受到干扰,并发出警报。气泡检测器在侦测到气泡时停止输注,以防止气泡进入血液,从而确保病患安全。透过快速检测气泡的存在并提醒医务人员,这些设备有助于维持静脉注射治疗的完整性并增强患者护理和安全。
由于医疗保健支出不断增加、患者安全意识不断增强、医疗设备技术进步等,预计亚太地区将在预测期内占据最大的市场占有率。中国、日本和印度等国家由于人口众多且医疗基础设施不断扩大,为市场扩张做出了巨大贡献。此外,旨在提高医疗保健品质和可近性的政府措施进一步推动了市场成长。
由于其严格的监管标准、完善的医疗基础设施以及对患者安全的关注,预计北美在预测期内将经历最高的复合年增长率。美国由于高额医疗保健支出和广泛采用先进医疗技术而在市场上占据主导地位。慢性病的增加和人口老化进一步推动了对气泡检测系统的需求。
According to Stratistics MRC, the Global Ultrasonic Air Bubble Detectors Market is accounted for $115.17 million in 2023 and is expected to reach $232.61 million by 2030 growing at a CAGR of 10.2% during the forecast period. Ultrasonic air bubble detectors are medical devices designed to detect and monitor the presence of air bubbles in fluid lines during medical procedures. These detectors utilize ultrasonic technology to identify and quantify air bubbles in real-time, helping to prevent potentially dangerous air embolisms from entering the bloodstream.
According to World Health Organization, nearly 17.9 million people use blood oxygenators that represent 32% globally.
Increasing incidence of chronic diseases
The increasing incidence of chronic diseases, such as diabetes and kidney failure, drives the demand for medical devices like infusion pumps and dialysis machines, which incorporate ultrasonic air bubble detectors. These detectors play a critical role in preventing complications associated with air embolisms, thereby ensuring patient safety during medical procedures. As the prevalence of chronic diseases continues to rise globally, there is a growing need for advanced healthcare technologies like ultrasonic air bubble detectors to support the management and treatment of these conditions, fueling market growth.
Integration complexities
Integration complexities in ultrasonic air bubble detectors relate to challenges in seamlessly incorporating these devices into existing medical equipment or designing them into new systems. These complexities can lead to delays in product development, increased costs, and difficulties in achieving regulatory compliance. As a result, healthcare providers may hesitate to adopt these detectors, hampering market growth due to concerns over integration challenges and associated risks.
Rising focus on minimizing healthcare costs
The increasing focus on minimizing healthcare costs drives the growth of the ultrasonic air bubble detectors by emphasizing the importance of preventative measures to avoid costly complications. These detectors help prevent air embolisms, reducing the need for additional treatments and hospital stays, thereby minimizing healthcare expenditures. By investing in technologies that enhance patient safety and reduce the likelihood of adverse events, healthcare providers can achieve cost savings in the long run, making ultrasonic air bubble detectors a valuable asset in cost-effective healthcare delivery.
High initial investments
High initial investments in ultrasonic air bubble detectors stem from the need for advanced sensor technology, precision manufacturing, and rigorous testing to ensure reliability and accuracy in medical settings. These costs can deter adoption, particularly for smaller healthcare facilities or those with limited budgets. The significant upfront investment may be perceived as prohibitive, hindering market growth as providers weigh the benefits against the financial outlay.
Covid-19 Impact
The covid-19 pandemic has had mixed impacts on the ultrasonic air bubble detectors market. While the increased demand for medical equipment, including infusion pumps and dialysis machines, have boosted the market, disruptions in supply chains and healthcare services have hampered growth. Additionally, shifts in healthcare priorities and budgetary constraints in response to the pandemic may have influenced purchasing decisions, potentially slowing market expansion. Overall, the pandemic has led to a complex and varied impact on the ultrasonic air bubble detectors market worldwide.
The doppler ultrasonic segment is expected to be the largest during the forecast period
The doppler ultrasonic segment is estimated to have a lucrative growth. Doppler ultrasonic air bubble detectors are medical devices used to monitor the flow of fluids, such as blood, during procedures like dialysis or cardiac surgeries. By emitting ultrasonic waves into the fluid, they detect the presence of air bubbles based on changes in frequency caused by bubble motion. They provide real-time monitoring, alerting medical professionals to potential risks, and allowing for immediate intervention to maintain patient safety during critical procedures.
The intravenous infusion segment is expected to have the highest CAGR during the forecast period
The intravenous infusion segment is anticipated to witness the highest CAGR growth during the forecast period. Ultrasonic air bubble detectors work by emitting ultrasonic waves into the fluid stream; any air bubbles disrupt the waves, triggering an alarm. These detectors ensure patient safety by halting infusion when air is detected, preventing air from entering the bloodstream. By promptly detecting and alerting medical staff to the presence of air bubbles, these devices help maintain the integrity of intravenous therapy, enhancing patient care and safety.
Asia Pacific is projected to hold the largest market share during the forecast period driven by rising healthcare expenditure, increasing awareness about patient safety, and technological advancements in medical devices. Countries like China, Japan, and India are key contributors to market expansion due to their large population bases and expanding healthcare infrastructure. Additionally, government initiatives aimed at improving healthcare quality and accessibility further propel market growth.
North America is projected to have the highest CAGR over the forecast period, fuelled by stringent regulatory standards, a well-established healthcare infrastructure, and a strong focus on patient safety. The United States dominates the market due to its large healthcare expenditure and extensive adoption of advanced medical technologies. Increasing incidences of chronic diseases, coupled with a growing geriatric population, further drive demand for air bubble detection systems.
Key players in the market
Some of the key players profiled in the Ultrasonic Air Bubble Detectors Market include Medtronic PLC, Baxter International Inc., GE Healthcare, Philips Healthcare, Smiths Medical, ICU Medical Inc., Nipro Corporation, Elcam Medical, Transonic Systems Inc., Sensirion AG, Moog Inc., PendoTECH, Sonotec Ultraschallsensorik Halle GmbH, Sonix GmbH, SMD Fluid Controls and Instrumens.
In August 2022, Instrumens, a pioneer in smart multi-sensor solutions, launched its new Bubble detection sensor. Easy to integrate into existing liquid control systems, Instrumems' bubble detection technology is a new measurement system for improved precision in liquid handling, leading to reduced errors.
In April 2022, SONOTEC has launched the second generation of the SONOFLOW CO.56 Pro flow-bubble sensor at MD&M West. The SONOFLOW CO.56 Pro V2.0 for medical applications measures the flow rate of liquids, such as blood and reliably detects air bubbles in standard medical tubing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.